SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
147<i>Or a real threat to currently public companies? Nah.</i> ...excnigel bates-4/17/2001
146This....... <i>``Like antibodies, fluorescent 'super' MIPs can bescaram(o)uche-4/17/2001
145What do you folks make of this? Hot air? Or a real threat to currently public tuck-4/17/2001
144Fremont, Calif. and London, Ontario, Canada – March 26, 2001 – Abgenix, Inc. (Nanigel bates-3/27/2001
143One of the most fascinating of efforts on earth. Keep a close eye on them. (eoscaram(o)uche-3/26/2001
142Did anyone ever take a look at Phylos (see - Message 14267115 and following postnigel bates-3/26/2001
141NEW YORK, March 23 /PRNewswire/ -- IMPATH Inc. (Nasdaq: IMPH - news), the nationnigel bates-3/23/2001
140This was in a 10k filed yesterday. It is probably more than you want or need buaknahow-3/22/2001
139Thanks. nignigel bates-3/22/2001
138No one has licensed the HE technology. Some of the 20 that have licensed the ceaknahow-3/22/2001
137The PR (any idea of the 20 licencees ? ) - March 22, 2001--XOMA Ltd. (Nasdaq:XOnigel bates-3/22/2001
136New humab patent. 164.195.100.11aknahow-3/21/2001
135MARTINSRIED and MUNICH, Germany, March 21 /PRNewswire/ -- MorphoSys AG (Neuer Manigel bates-3/21/2001
134Monday March 19, 1:18 pm Eastern Time Morphosys disappoints on results (UPDATE: keokalani'nui-3/19/2001
133March 19 /PRNewswire/ -- MorphoSys (Neuer Markt: MOR) today announced its financnigel bates-3/19/2001
132REHOVOT, Israel and NEW IPSWICH, N.H., March 19 /PRNewswire/ -- XTL Biopharmaceunigel bates-3/19/2001
131PDLI keeps on signing deals too... Message 15492774nigel bates-3/13/2001
130LEIDEN, Netherlands, March 12 /PRNewswire/ -- Crucell N.V. (Nasdaq: CRXL; EAX Amnigel bates-3/12/2001
129March 8 /PRNewswire/ -- Genmab A/S (CSE: GEN and Neuer Markt: GE9D) announced tonigel bates-3/8/2001
128biospace.com <i>Now for an interesting science tidbit. A recent report inscaram(o)uche-2/27/2001
127Feb. 26 /PRNewswire/ -- Medarex, Inc. (Nasdaq: MEDX - news) and Biosite Diagnostnigel bates-2/26/2001
126>> Too many more deals like this & I'll begin to seriously doubt tscaram(o)uche-2/15/2001
125And what the heck do they know about making monoclonals at Cambridge? Sheeeesh,scaram(o)uche-2/14/2001
124Not exactly a "company" but definitely "HuMAb" pnas.org &lPseudo Biologist-2/14/2001
123Hi Richard, Thanks again, This site might be of interest for other drugs than DNElmer-2/13/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News